Company profile
Secretome Therapeutics
Secretome is a clinical-stage company focused on orphan and underserved cardiac diseases
- Industry
- Biotechnology Research
- Employees
- 22
- Headquarters
- Baltimore, Maryland
- Founded
- 2018
- LinkedIn followers
- 2,687
- Office locations
- 1
Secretome Therapeutics company summary
Secretome Therapeutics is a company in the Biotechnology Research industry, headquartered in Baltimore, Maryland, founded in 2018. On LinkedIn the company has around 22 employees and 2,687 followers.
What technology does Secretome Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Secretome Therapeutics
Secretome Therapeutics is a clinical-stage cell therapy company focused on orphan and underserved cardiac diseases. STM-01, the lead drug, is a neonatal cardiac progenitor cell (nCPC) isolated from cardiac tissue excised during life-saving, open-heart surgery on newborns with congenital heart defects. The main target indication for STM-01 is Duchenne muscular dystrophy-associated cardiomyopathy (DMD-CM).
Where is Secretome Therapeutics located?
Secretome Therapeutics lists 1 location.
Compare companies similar to Secretome Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Secretome Therapeutics secretometherapeutics.com | Biotechnology Research | 22 | 2018 | Baltimore, Maryland |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Secretome Therapeutics
What does Secretome Therapeutics do?
Secretome Therapeutics is a clinical-stage cell therapy company focused on orphan and underserved cardiac diseases. STM-01, the lead drug, is a neonatal cardiac progenitor cell (nCPC) isolated from cardiac tissue excised during life-saving, open-heart surgery on newborns with congenital heart defects. The main target indication for STM-01 is Duchenne muscular dystrophy-associated cardiomyopathy (DMD-CM).
How many employees does Secretome Therapeutics have?
Secretome Therapeutics has around 22 employees on LinkedIn.
Where is Secretome Therapeutics headquartered?
Secretome Therapeutics is headquartered in Baltimore, Maryland.
When was Secretome Therapeutics founded?
Secretome Therapeutics was founded in 2018.
Build a lead list from companies like Secretome Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.